Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.
D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003037:Cobalt Radioisotopes; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011239:Prednisolone / Q000627:therapeutic use; D011867:Radioisotope Teletherapy; D014750:Vincristine / Q000627:therapeutic use
D003037:Cobalt Radioisotopes; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone